Monitoring Response to Neoadjuvant Chemotherapy in HER2 Negative Breast Cancer Using High-speed MR Spectroscopic Imaging
Status: RECRUITING
Study type: OBSERVATIONAL
Conditions: HER2 Negative Breast Cancer
Interventions: OTHER: Response monitoring (no intervention)
Sponsor: New Mexico Cancer Care Alliance